The European Medicines Agency (EMA) has published an updated version of its good clinical practice questions and answers (#GCP Q&A).
EMA provides guidance in forms of questions and answers on GCP, as discussed and agreed by the GCP Inspectors Working Group.
The March 2022 updates relate to:
Investigational medicinal products (IMPs) in bioavailability and bioequivalence trials:
✔️ labelling of Investigational Medicinal Products (IMPs),
✔️ deviations from inclusion/exclusion criteria of an approved protocol,
✔️ subcontracting and related sponsor & investigator responsibilities,
✔️ the definition of source data,
✔️ contractual agreements with vendors for electronic systems,
GCP matters:
✔️ audits of IMP manufacturers by the sponsor,
✔️ GCP inspectors’ right to inspect trial participants’ medical records and associated implications for Informed Consent Forms,
Records of study subject data relating to clinical trials:
✔️ considerations when transferring copies of medical records to clinical trial sponsors or their service providers.
Meditrial offers solutions in Pharma Regulatory, Quality Assurance and and Pre/Post Market Pharmacovigilance.
Get in touch today!
Table of Contents
Latest Articles
Practical 510(k) vs PMA vs De Novo FDA Pathway Guide
Practical 510(k) vs PMA vs De Novo guidance for choosing an FDA device pathway based on classification, predicates, risk, and evidence needs
Build a Defensible Clinical Evidence Strategy Under EU MDR
Build a defensible clinical evidence strategy under MDR Annex XIV, from the clinical evaluation plan to PMCF and notified body review.
Getting a CE mark for medical devices: a step-by-step guide
Practical guidance on the CE mark for medical devices under EU MDR, from classification and evidence to conformity assessment and EUDAMED
This article provides general information and does not constitute regulatory, legal, clinical, or compliance advice. Requirements and appropriate processes may vary by study, product, jurisdiction, and organization. Medigen Suite functionality should be used in accordance with applicable regulations, study documentation, and internal procedures.
